Cargando…

The evaluation of a tissue-engineered cardiac patch seeded with hips derived cardiac progenitor cells in a rat left ventricular model

BACKGROUND: Ventricular septal perforation and left ventricular aneurysm are examples of potentially fatal complications of myocardial infarction. While various artificial materials are used in the repair of these issues, the possibility of associated infection and calcification is non-negligible. C...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuzaki, Yuichi, Miyamoto, Shinka, Miyachi, Hideki, Sugiura, Tadahisa, Reinhardt, James W., Yu-Chun, Chang, Zbinden, Jacob, Breuer, Christopher K., Shinoka, Toshiharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279601/
https://www.ncbi.nlm.nih.gov/pubmed/32511282
http://dx.doi.org/10.1371/journal.pone.0234087
_version_ 1783543598438940672
author Matsuzaki, Yuichi
Miyamoto, Shinka
Miyachi, Hideki
Sugiura, Tadahisa
Reinhardt, James W.
Yu-Chun, Chang
Zbinden, Jacob
Breuer, Christopher K.
Shinoka, Toshiharu
author_facet Matsuzaki, Yuichi
Miyamoto, Shinka
Miyachi, Hideki
Sugiura, Tadahisa
Reinhardt, James W.
Yu-Chun, Chang
Zbinden, Jacob
Breuer, Christopher K.
Shinoka, Toshiharu
author_sort Matsuzaki, Yuichi
collection PubMed
description BACKGROUND: Ventricular septal perforation and left ventricular aneurysm are examples of potentially fatal complications of myocardial infarction. While various artificial materials are used in the repair of these issues, the possibility of associated infection and calcification is non-negligible. Cell-seeded biodegradable tissue-engineered patches may be a potential solution. This study evaluated the feasibility of a new left ventricular patch rat model to study neotissue formation in biodegradable cardiac patches. METHODS: Human induced pluripotent stem cell-derived cardiac progenitor cells (hiPS-CPCs) were cultured onto biodegradable patches composed of polyglycolic acid and a 50:50 poly (l-lactide-co-ε-caprolactone) copolymer for one week. After culturing, patches were implanted into left ventricular walls of male athymic rats. Unseeded controls were also used (n = 10/group). Heart conditions were followed by echocardiography and patches were subsequently explanted at 1, 2, 6, and 9 months post-implantation for histological evaluation. RESULT: Throughout the study, no patches ruptured demonstrating the ability to withstand the high pressure left ventricular system. One month after transplantation, the seeded patch did not stain positive for human nuclei. However, many new blood vessels formed within patches with significantly greater vessels in the seeded group at the 6 month time point. Echocardiography showed no significant difference in left ventricular contraction rate between the two groups. Calcification was found inside patches after 6 months, but there was no significant difference between groups. CONCLUSION: We have developed a surgical method to implant a bioabsorbable scaffold into the left ventricular environment of rats with a high survival rate. Seeded hiPS-CPCs did not differentiate into cardiomyocytes, but the greater number of new blood vessels in seeded patches suggests the presence of cell seeding early in the remodeling process might provide a prolonged effect on neotissue formation. This experiment will contribute to the development of a treatment model for left ventricular failure using iPS cells in the future.
format Online
Article
Text
id pubmed-7279601
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-72796012020-06-17 The evaluation of a tissue-engineered cardiac patch seeded with hips derived cardiac progenitor cells in a rat left ventricular model Matsuzaki, Yuichi Miyamoto, Shinka Miyachi, Hideki Sugiura, Tadahisa Reinhardt, James W. Yu-Chun, Chang Zbinden, Jacob Breuer, Christopher K. Shinoka, Toshiharu PLoS One Research Article BACKGROUND: Ventricular septal perforation and left ventricular aneurysm are examples of potentially fatal complications of myocardial infarction. While various artificial materials are used in the repair of these issues, the possibility of associated infection and calcification is non-negligible. Cell-seeded biodegradable tissue-engineered patches may be a potential solution. This study evaluated the feasibility of a new left ventricular patch rat model to study neotissue formation in biodegradable cardiac patches. METHODS: Human induced pluripotent stem cell-derived cardiac progenitor cells (hiPS-CPCs) were cultured onto biodegradable patches composed of polyglycolic acid and a 50:50 poly (l-lactide-co-ε-caprolactone) copolymer for one week. After culturing, patches were implanted into left ventricular walls of male athymic rats. Unseeded controls were also used (n = 10/group). Heart conditions were followed by echocardiography and patches were subsequently explanted at 1, 2, 6, and 9 months post-implantation for histological evaluation. RESULT: Throughout the study, no patches ruptured demonstrating the ability to withstand the high pressure left ventricular system. One month after transplantation, the seeded patch did not stain positive for human nuclei. However, many new blood vessels formed within patches with significantly greater vessels in the seeded group at the 6 month time point. Echocardiography showed no significant difference in left ventricular contraction rate between the two groups. Calcification was found inside patches after 6 months, but there was no significant difference between groups. CONCLUSION: We have developed a surgical method to implant a bioabsorbable scaffold into the left ventricular environment of rats with a high survival rate. Seeded hiPS-CPCs did not differentiate into cardiomyocytes, but the greater number of new blood vessels in seeded patches suggests the presence of cell seeding early in the remodeling process might provide a prolonged effect on neotissue formation. This experiment will contribute to the development of a treatment model for left ventricular failure using iPS cells in the future. Public Library of Science 2020-06-08 /pmc/articles/PMC7279601/ /pubmed/32511282 http://dx.doi.org/10.1371/journal.pone.0234087 Text en © 2020 Matsuzaki et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Matsuzaki, Yuichi
Miyamoto, Shinka
Miyachi, Hideki
Sugiura, Tadahisa
Reinhardt, James W.
Yu-Chun, Chang
Zbinden, Jacob
Breuer, Christopher K.
Shinoka, Toshiharu
The evaluation of a tissue-engineered cardiac patch seeded with hips derived cardiac progenitor cells in a rat left ventricular model
title The evaluation of a tissue-engineered cardiac patch seeded with hips derived cardiac progenitor cells in a rat left ventricular model
title_full The evaluation of a tissue-engineered cardiac patch seeded with hips derived cardiac progenitor cells in a rat left ventricular model
title_fullStr The evaluation of a tissue-engineered cardiac patch seeded with hips derived cardiac progenitor cells in a rat left ventricular model
title_full_unstemmed The evaluation of a tissue-engineered cardiac patch seeded with hips derived cardiac progenitor cells in a rat left ventricular model
title_short The evaluation of a tissue-engineered cardiac patch seeded with hips derived cardiac progenitor cells in a rat left ventricular model
title_sort evaluation of a tissue-engineered cardiac patch seeded with hips derived cardiac progenitor cells in a rat left ventricular model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279601/
https://www.ncbi.nlm.nih.gov/pubmed/32511282
http://dx.doi.org/10.1371/journal.pone.0234087
work_keys_str_mv AT matsuzakiyuichi theevaluationofatissueengineeredcardiacpatchseededwithhipsderivedcardiacprogenitorcellsinaratleftventricularmodel
AT miyamotoshinka theevaluationofatissueengineeredcardiacpatchseededwithhipsderivedcardiacprogenitorcellsinaratleftventricularmodel
AT miyachihideki theevaluationofatissueengineeredcardiacpatchseededwithhipsderivedcardiacprogenitorcellsinaratleftventricularmodel
AT sugiuratadahisa theevaluationofatissueengineeredcardiacpatchseededwithhipsderivedcardiacprogenitorcellsinaratleftventricularmodel
AT reinhardtjamesw theevaluationofatissueengineeredcardiacpatchseededwithhipsderivedcardiacprogenitorcellsinaratleftventricularmodel
AT yuchunchang theevaluationofatissueengineeredcardiacpatchseededwithhipsderivedcardiacprogenitorcellsinaratleftventricularmodel
AT zbindenjacob theevaluationofatissueengineeredcardiacpatchseededwithhipsderivedcardiacprogenitorcellsinaratleftventricularmodel
AT breuerchristopherk theevaluationofatissueengineeredcardiacpatchseededwithhipsderivedcardiacprogenitorcellsinaratleftventricularmodel
AT shinokatoshiharu theevaluationofatissueengineeredcardiacpatchseededwithhipsderivedcardiacprogenitorcellsinaratleftventricularmodel
AT matsuzakiyuichi evaluationofatissueengineeredcardiacpatchseededwithhipsderivedcardiacprogenitorcellsinaratleftventricularmodel
AT miyamotoshinka evaluationofatissueengineeredcardiacpatchseededwithhipsderivedcardiacprogenitorcellsinaratleftventricularmodel
AT miyachihideki evaluationofatissueengineeredcardiacpatchseededwithhipsderivedcardiacprogenitorcellsinaratleftventricularmodel
AT sugiuratadahisa evaluationofatissueengineeredcardiacpatchseededwithhipsderivedcardiacprogenitorcellsinaratleftventricularmodel
AT reinhardtjamesw evaluationofatissueengineeredcardiacpatchseededwithhipsderivedcardiacprogenitorcellsinaratleftventricularmodel
AT yuchunchang evaluationofatissueengineeredcardiacpatchseededwithhipsderivedcardiacprogenitorcellsinaratleftventricularmodel
AT zbindenjacob evaluationofatissueengineeredcardiacpatchseededwithhipsderivedcardiacprogenitorcellsinaratleftventricularmodel
AT breuerchristopherk evaluationofatissueengineeredcardiacpatchseededwithhipsderivedcardiacprogenitorcellsinaratleftventricularmodel
AT shinokatoshiharu evaluationofatissueengineeredcardiacpatchseededwithhipsderivedcardiacprogenitorcellsinaratleftventricularmodel